Leap Therapeutics, Inc. (LPTX) earnings
LPTX earnings moved a median of -3.12% by the close. Quarterly and annual LPTX reports and results, each read against the price at its own news timestamp. Back to the LPTX overview →
16 measured LPTX earnings events.
Where these LPTX earnings landedvs 14 measured LPTX earnings reactions
| Middle 50% of LPTX earnings reactions | -6.87% to +2.44% |
|---|---|
| Median reaction (to close) | -3.12% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 LPTX earnings events with a measured close landed between -6.87% and +2.44%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results | Press release | +9.57% | — | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +9.57% | — | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | -3.08% | -18.80% | |
| Leap Therapeutics Reports Second Quarter 2025 Financial Results | Press release | -3.08% | -18.80% | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +1.50% | +7.01% | |
| Leap Therapeutics Reports First Quarter 2025 Financial Results | Press release | +1.50% | +7.01% | |
| Form 10-K LEAP THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +2.79% | -3.51% | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +6.77% | -7.69% | |
| Leap Therapeutics Reports Third Quarter 2024 Financial Results | Press release | +6.77% | -7.69% | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | -3.53% | -4.42% | |
| Leap Therapeutics Reports Second Quarter 2024 Financial Results | Press release | -3.53% | -4.42% | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.72% | +2.54% | |
| Leap Therapeutics Reports First Quarter 2024 Financial Results | Press release | +0.72% | +2.54% | |
| Form 10-K LEAP THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +1.81% | -2.73% | |
| Form 10-Q LEAP THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +1.79% | +2.14% | |
| Leap Therapeutics Reports Third Quarter 2023 Financial Results | Press release | +1.79% | +2.14% |
Keep exploring
More LPTX: analyst actions → · SEC filings → · LPTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| NeuroMetrix, Inc. (NURO) | 157 | -0.49% | 30% |
| GOLD FINDER RES LTD (GLDFF) | 155 | +0.19% | 52% |
| MESOBLAST LTD ORD (MEOBF) | 155 | 0.00% | 5% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.